Rhamy Zeid

Company: Nexo Therapeutics

Job title: Vice President, Head of Biology

Seminars:

Panel Discussion: : Examining Funding & Investor Perspectives to Fulfil the Future Opportunities of Covalent Drug Discovery & Development 10:15 am

What is investible in the current market? What do investors look for when investing in covalent pipelines? Is a particular target or indication of interest? How to spark interest from funding and collaboration partners and discussing how assets are considered versus platforms? What are the challenges of the covalency modality and bringing these to the…Read more

day: Conference Day Two

Covalent Fragment-Based Ligand Discovery to Drug Refractory Targets 5:00 pm

How can covalent fragment-based ligand discovery be leveraged to tackle so-called undruggable targets? What are the advantages of a target-centric approach to covalent fragment-based ligand discovery? What approaches (biochemical and cell-based) can be deployed to progress covalent fragment starting points to mature lead molecules within a drug discovery campaign? Read more

day: Conference Day One